Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug approvals
Pharma
X4 snags FDA approval for its first drug Xolremdi
X4 Pharmaceuticals has made its commercial debut thanks to Monday’s FDA approval of the company’s CXCR4 inhibitor Xolremdi in WHIM syndrome.
Fraiser Kansteiner
Apr 29, 2024 11:28am
Day One pressures Novartis with FDA nod for novel RAF inhibitor
Apr 23, 2024 10:13pm
Soon-Shiong's ImmunityBio bags FDA nod for bladder cancer drug
Apr 22, 2024 10:40pm
BeiGene finally snags FDA approval for PD-1 drug Tevimbra
Mar 15, 2024 8:39am
FDA approves first drug for MASH in Madrigal's Rezdiffra
Mar 14, 2024 3:56pm
FDA approves first T-cell therapy for a solid tumor
Feb 17, 2024 12:15pm